{"entity":{"type":"insider","cik":"0001614578","url":"/insider/0001614578","json_url":"/insider/0001614578.json","name":"Lian Brian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":18,"first":"2023-04-03","last":"2026-07-29","span_basis":"filed_date"},"name_variants":[{"name":"Lian Brian","source":"filing","n_filings":18,"first_seen":"2023-04-03","last_seen":"2026-07-29"}],"transactions":[{"id":6235840,"accession":"0001193125-26-324448","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-324448","line_url":"/filing/0001193125-26-324448#line-2","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":148517.0,"shares_display":"148,517","price_per_share":33.3153,"price_display":"33.32","price_state":"stated","total_value":4947888.4101,"total_display":"4,947,888.41","total_whole":"4,947,888","shares_owned_after":2572441.0,"shares_owned_after_display":"2,572,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-29","filed_date":"2026-07-29","scope":"insider"},{"id":5846716,"accession":"0001193125-26-003113","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-26-003113","line_url":"/filing/0001193125-26-003113","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233409.0,"shares_display":"233,409","price_per_share":32.95554430077675,"price_display":"32.96","price_state":"stated","total_value":7692120.6397,"total_display":"7,692,120.64","total_whole":"7,692,121","shares_owned_after":2600246.0,"shares_owned_after_display":"2,600,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider","n_lines":4},{"id":4701733,"accession":"0001193125-25-254299","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-254299","line_url":"/filing/0001193125-25-254299#line-2","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38989.0,"shares_display":"38,989","price_per_share":35.0079,"price_display":"35.01","price_state":"stated","total_value":1364923.0131,"total_display":"1,364,923.01","total_whole":"1,364,923","shares_owned_after":2419109.0,"shares_owned_after_display":"2,419,109","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-28","filed_date":"2025-10-28","scope":"insider"},{"id":4100925,"accession":"0000950170-25-093793","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-093793","line_url":"/filing/0000950170-25-093793#line-2","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26889.0,"shares_display":"26,889","price_per_share":27.8044,"price_display":"27.80","price_state":"stated","total_value":747632.5116,"total_display":"747,632.51","total_whole":"747,633","shares_owned_after":2388014.0,"shares_owned_after_display":"2,388,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-03","filed_date":"2025-07-03","scope":"insider"},{"id":4832196,"accession":"0000950170-25-002487","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-002487","line_url":"/filing/0000950170-25-002487","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":194490.0,"shares_display":"194,490","price_per_share":42.7456484240835,"price_display":"42.75","price_state":"stated","total_value":8313601.162,"total_display":"8,313,601.16","total_whole":"8,313,601","shares_owned_after":2385570.0,"shares_owned_after_display":"2,385,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-06","scope":"insider","n_lines":2},{"id":2550819,"accession":"0000950170-24-108576","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-108576","line_url":"/filing/0000950170-24-108576","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":216130.0,"shares_display":"216,130","price_per_share":70.83030074584741,"price_display":"70.83","price_state":"stated","total_value":15308552.9002,"total_display":"15,308,552.90","total_whole":"15,308,553","shares_owned_after":2305127.0,"shares_owned_after_display":"2,305,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-20","filed_date":"2024-09-20","scope":"insider","n_lines":3},{"id":2237710,"accession":"0000950170-24-099982","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-099982","line_url":"/filing/0000950170-24-099982#line-2","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":69.9,"price_display":"69.90","price_state":"stated","total_value":69900.0,"total_display":"69,900.00","total_whole":"69,900","shares_owned_after":2354927.0,"shares_owned_after_display":"2,354,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-22","scope":"insider"},{"id":2679414,"accession":"0000950170-24-098803","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-098803","line_url":"/filing/0000950170-24-098803","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":112870.0,"shares_display":"112,870","price_per_share":65.79700259590679,"price_display":"65.80","price_state":"stated","total_value":7426507.683,"total_display":"7,426,507.68","total_whole":"7,426,508","shares_owned_after":2397665.0,"shares_owned_after_display":"2,397,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-19","scope":"insider","n_lines":3},{"id":2589405,"accession":"0000950170-24-088544","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-088544","line_url":"/filing/0000950170-24-088544","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115859.0,"shares_display":"115,859","price_per_share":57.575190705944294,"price_display":"57.58","price_state":"stated","total_value":6670604.02,"total_display":"6,670,604.02","total_whole":"6,670,604","shares_owned_after":2404845.0,"shares_owned_after_display":"2,404,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-30","filed_date":"2024-07-31","scope":"insider","n_lines":3},{"id":2516923,"accession":"0001209191-24-003068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-003068","line_url":"/filing/0001209191-24-003068#line-1","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":29.9,"price_display":"29.90","price_state":"stated","total_value":1345500.0,"total_display":"1,345,500.00","total_whole":"1,345,500","shares_owned_after":2139882.0,"shares_owned_after_display":"2,139,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-09","filed_date":"2024-02-09","scope":"insider"},{"id":2916329,"accession":"0001209191-24-003010","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-24-003010","line_url":"/filing/0001209191-24-003010","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":269079.0,"shares_display":"269,079","price_per_share":26.87234696873409,"price_display":"26.87","price_state":"stated","total_value":7230784.25,"total_display":"7,230,784.25","total_whole":"7,230,784","shares_owned_after":2264882.0,"shares_owned_after_display":"2,264,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-08","filed_date":"2024-02-08","scope":"insider","n_lines":5},{"id":2842905,"accession":"0001209191-24-002512","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-002512","line_url":"/filing/0001209191-24-002512","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85000.0,"shares_display":"85,000","price_per_share":24.71470588235294,"price_display":"24.71","price_state":"stated","total_value":2100750.0,"total_display":"2,100,750.00","total_whole":"2,100,750","shares_owned_after":2264882.0,"shares_owned_after_display":"2,264,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-01-31","scope":"insider","n_lines":2},{"id":2213668,"accession":"0001209191-24-002458","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-002458","line_url":"/filing/0001209191-24-002458#line-2","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":23.95,"price_display":"23.95","price_state":"stated","total_value":838250.0,"total_display":"838,250.00","total_whole":"838,250","shares_owned_after":2264882.0,"shares_owned_after_display":"2,264,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-01-30","scope":"insider"},{"id":8495443,"accession":"0001209191-23-026356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-026356","line_url":"/filing/0001209191-23-026356#line-1","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":22.45,"price_display":"22.45","price_state":"stated","total_value":1010250.0,"total_display":"1,010,250.00","total_whole":"1,010,250","shares_owned_after":2197963.0,"shares_owned_after_display":"2,197,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-01","scope":"insider"},{"id":8544799,"accession":"0001209191-23-025277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-025277","line_url":"/filing/0001209191-23-025277#line-1","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":21.45,"price_display":"21.45","price_state":"stated","total_value":750750.0,"total_display":"750,750.00","total_whole":"750,750","shares_owned_after":2242963.0,"shares_owned_after_display":"2,242,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-19","filed_date":"2023-04-21","scope":"insider"},{"id":8332346,"accession":"0001209191-23-024724","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-024724","line_url":"/filing/0001209191-23-024724#line-2","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155000.0,"shares_display":"155,000","price_per_share":20.4501,"price_display":"20.45","price_state":"stated","total_value":3169765.5,"total_display":"3,169,765.50","total_whole":"3,169,766","shares_owned_after":2277963.0,"shares_owned_after_display":"2,277,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-18","scope":"insider"},{"id":7814606,"accession":"0001209191-23-024228","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-024228","line_url":"/filing/0001209191-23-024228#line-2","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79336.0,"shares_display":"79,336","price_per_share":18.45,"price_display":"18.45","price_state":"stated","total_value":1463749.2,"total_display":"1,463,749.20","total_whole":"1,463,749","shares_owned_after":2307963.0,"shares_owned_after_display":"2,307,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-13","filed_date":"2023-04-13","scope":"insider"},{"id":7810900,"accession":"0001209191-23-022400","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-23-022400","line_url":"/filing/0001209191-23-022400#line-9","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22000.0,"shares_display":"22,000","price_per_share":17.85,"price_display":"17.85","price_state":"stated","total_value":392700.0,"total_display":"392,700.00","total_whole":"392,700","shares_owned_after":2232963.0,"shares_owned_after_display":"2,232,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-03","scope":"insider"},{"id":7810892,"accession":"0001209191-23-022400","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-022400","line_url":"/filing/0001209191-23-022400#line-6","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67970.0,"shares_display":"67,970","price_per_share":17.45,"price_display":"17.45","price_state":"stated","total_value":1186076.5,"total_display":"1,186,076.50","total_whole":"1,186,077","shares_owned_after":2254963.0,"shares_owned_after_display":"2,254,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-31","filed_date":"2023-04-03","scope":"insider"},{"id":7810887,"accession":"0001209191-23-022400","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-022400","line_url":"/filing/0001209191-23-022400","is_derivative":false,"issuer_cik":"0001607678","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001607678","owner_cik":"0001614578","owner_name":"Lian Brian","owner_display_name":"Lian Brian","owner_url":"/insider/0001614578","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":153382.0,"shares_display":"153,382","price_per_share":17.16313452686756,"price_display":"17.16","price_state":"stated","total_value":2632515.9,"total_display":"2,632,515.90","total_whole":"2,632,516","shares_owned_after":2320345.0,"shares_owned_after_display":"2,320,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-30","filed_date":"2023-04-03","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":36,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001607678","name":"Viking Therapeutics, Inc.","url":"/issuer/0001607678","role":"Director, Officer (President & CEO)","n_filings":18,"first_seen":"2023-04-03","last_seen":"2026-07-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001614578","retrieved_at":"2026-08-23T23:41:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}